Australian researchers discover anti-parasite drug that kills COVID-19
Category: #health  By Nikita Chaurasia  Date: 2020-04-07
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Australian researchers discover anti-parasite drug that kills COVID-19

Researchers at Monash University, Melbourne, have reportedly announced that they discovered that an anti-parasite medicine can kill the novel strain of the coronavirus (SARS-CoV-2) that has currently brought the world to a standstill.

In a study published on Friday, university scientists stated that one dose of Ivermectin can halt SARS-CoV-2, the virus that is responsible for COVID-19, from expanding in cell culture in less than 48 hours. Ivermectin is available everywhere across the world.

Ivermectin is an anti-parasitic drug approved by FDA which has also proved to be effective against other viruses that also includes dengue, influenza, and HIV viruses. 

The research leader, Kylie Wagstaff stated that the research found that even one dose can significantly remove all viral RNA in 48 hours. The study also found that within 24 hours there was a substantial reduction in the virus.

Wagstaff stated that the working mechanism of Ivermectin on the coronavirus was not known yet, but on the basis of how the drug reacted with other viruses, the drug probably restricted the COVID-19, dampening down the ability of host cells to clear it.

The next aim of Australian scientists is to determine if it would safely work for humans as well.

Wagstaff further added that Ivermectin is used widely and is a safe drug. The team needs just needs to figure out if the dosage can be used in humans and if it works effectively. In these times where the world is going through a global pandemic with no approved treatment options for the growing outbreak, there is a compound readily available across the globe that might possibly help people much sooner. However, realistically, it will take some time before a proper vaccine is available globally.

The use of this anti-parasitic drug to cure coronavirus would now depend on the outcomes of further pre-clinical trials and then clinical testing, with funds that are urgently required to continue this research.

Source credit: http://www.koreatimes.co.kr/www/news/nation/2020/04/119_287410.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Mercedes-Benz unveils the S-Class of EVs, comes with a 56-inch display

Mercedes-Benz unveils the S-Class of EVs, comes with a 56-inch display

By Nikita Chaurasia

Mercedes-Benz, a German multinational automaker of luxury and commercial vehicles, has unveiled its flagship electric sedan, the EQS. The new vehicle is likely to allow Mercedes to take on Tesla Inc., as the market for electric vehicles (EVs) continu...

Ford takes on GM, Tesla by debuting its first hands-free driving system

Ford takes on GM, Tesla by debuting its first hands-free driving system

By Nikita Chaurasia

Ford Motor Company, the American multinational automaker, is reportedly planning on introducing a hands-free driving feature on its 2021 Mustang Models as well as 2021 F-150 pickup truck through a software update, by the end of the year. The automob...

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

By Nikita Chaurasia

Oculus, a subsidiary of Facebook, Inc., that develops and manufactures virtual reality headsets, has recently announced that Oculus Quest 2’s new v28 software update will include native wireless desktop PC streaming as well as 120 Hz refresh ra...